This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Ultromics Limited. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Arian Beqiri: Innovator in Cardiac Assessment Technology
Introduction
Arian Beqiri is a notable inventor based in Oxfordshire, GB. He has made significant contributions to the field of cardiac assessment through his innovative use of neural networks. His work focuses on enhancing the accuracy and efficiency of heart parameter assessments using advanced technology.
Latest Patents
Arian Beqiri holds a patent for "Assessing heart parameters using neural networks." This invention provides a system for automatically deriving parameters of a human heart from ultrasound results. A first neural network classifies echocardiographic images into two categories: a two-chamber view and a four-chamber view. A second neural network identifies the endocardial border of the left ventricle (LV) for each view. The system then calculates important parameters such as LV volume, ejection fraction, global longitudinal strain, and regional longitudinal strain from the identified end-systole and end-diastole images.
Career Highlights
Arian Beqiri is associated with Ultromics Limited, a company that focuses on leveraging artificial intelligence to improve cardiac care. His work at Ultromics has positioned him as a key player in the intersection of technology and healthcare.
Collaborations
Arian collaborates with talented individuals such as Andrew Richard Parker and Jurriath Azmathi Mumith. Their combined expertise contributes to the advancement of innovative solutions in cardiac assessment.
Conclusion
Arian Beqiri's contributions to cardiac assessment technology through his patent and work at Ultromics Limited highlight the importance of innovation in healthcare. His efforts are paving the way for more accurate and efficient heart assessments, ultimately benefiting patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile